China’s massive investment in Guinea’s Simandou mine represents the largest untapped iron ore deposit on Earth. This $20 billion project threatens to reshape global steel markets and challenge Australia’s iron ore supremacy.
New research from Anthropic shows AI models developing introspection-like capabilities. This emerging self-awareness could revolutionize AI safety or create dangerously deceptive systems that understand their own internal states.
Roy Lee’s calculated controversy with Cluely demonstrates how rage bait can accelerate startup awareness. But this high-risk strategy comes with lasting consequences for founders and the hiring technology ecosystem.
Artificial intelligence is evolving from lab assistant to lead investigator in medical research. This transformation promises to reshape healthcare markets, drug development timelines, and investment strategies across the industry.
Nvidia has become the first $5 trillion company in history, driven by the AI revolution. This unprecedented valuation signals a fundamental shift in how markets value technology infrastructure. Here’s what it means for investors and the broader economy.
Chinese manufacturer ORICO has launched a mini PC that directly mimics Apple’s iconic Mac Pro cheese-grater design. The Omini Pro features AMD’s Ryzen 7 8845HS processor and starts at just $379 during pre-sales, blending premium aesthetics with PC affordability.
Hizbollah-linked charities are exploiting digital payment platforms to bypass sanctions, using individual wallets rather than official accounts. This exposes critical weaknesses in global financial security systems despite partnerships with major US payment companies.
Microsoft’s long-awaited Windows 11 Start menu redesign has arrived with some baffling bugs. Newly installed apps fail to appear, and erratic scrolling disrupts user interaction. These issues highlight ongoing quality challenges.
OpenAI CEO Sam Altman says the company’s revenue already exceeds reported $13 billion and could reach $100 billion by 2027. But with massive infrastructure investments and ongoing losses, can this explosive growth actually be sustained?
Vaccine developer Inventprise is cutting 76 workers across its Washington facilities, representing nearly 40% of its workforce. The layoffs come as the company advances its pneumococcal vaccine candidate through clinical trials.
